CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shanghai Ruiyi Medical Technology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shanghai Ruiyi Medical Technology Co Ltd
Room 1205
No.955 Jianchuan Road, Minhang District
Phone: +86 2154711706p:+86 2154711706 SHANGHAI, SHA  China Fax: +86 2154711707f:+86 2154711707

Business Summary
Shanghai Ruiyi Medical Technology Co Ltd is a China-based innovative drug intermediates manufacturer. It conducts research and development services for and manufactures medical organosilicon intermediates, reagents of organic synthesis and other pharmaceutical material intermediates. The main products includes organic silicon series, heterocyclic series, organic alkyne series, organoboron series and fluoride series.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201412/31/2014Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

General Information
Outstanding Shares: 19,094,285 (As of 12/31/2014)
Fax Number: +86 2154711707


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023